Pirandai Uppu- A Siddha Internal Medicine for Osteoarthritis of Knee Joint.

Clinical trial on Efficacy of Pirandai Uppu in Osteoarthritis of Knee Joint - NIL

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067721

Enrollment

Registered

2024-05-21

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M179- Osteoarthritis of knee, unspecified

Interventions

Intervention1: Pirandai Uppu: It is a Siddha Herbomineral formulation administered orally in the dosage of 500mg BID for a period of 30 days. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Radiological examination WOMAC Index Score

Exclusion criteria

Exclusion criteria: 1.Start of any new treatment for Knee OA during 4 weeks preceding enrollment. 2.Invasive measures at knee joint in the 12 weeks preceding enrollment or planned for the 1 year following enrollment. 3.Chronic co-morbid conditions. 4.Knee surgery or knee arthroscopy 5.Subjected to Intra-articular injections into the knee joint 6.Popliteal vein thrombosis 7.Rheumatoid arthritis 8.Autoimmune diseases 9.Congenital dysplasia 10.Fracture

Design outcomes

Primary

Measure	Time frame
The outcome of the study will be improvement in the patient which is assessed clinically and using Womac Index Score.Timepoint: 30 Days	—

Secondary

Measure	Time frame
Reduction in pain,stiffness and improved mobility assessed using WOMAC Index Score.Timepoint: 60 Days	—

Countries

India

Contacts

Public ContactDr S Kanimozhi

Sri Sairam Siddha Medical College and Research Centre.

kanimozhi@sairamsiddha.edu.in9941193847

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026